Investigations of Anti-Inflammatory Activity of a Peptide-Based Hydrogel Using Rat Air Pouch Model. 2019

Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
Department of Chemistry , Indian Institute of Technology Indore , Indore 453552 , India.

The growing area of biomaterial sciences has attracted broad attention in recent years in the development of peptide-based biocompatible materials with inherent therapeutic potentials. Here, we developed an Amoc (9-anthracenemethoxycarbonyl)-capped dipeptide-based biocompatible, injectable, thixotropic, and self-healable hydrogel. In vitro cytotoxicity of the hydrogel was investigated with the human embryonic kidney cell (HEK293) line. We observed that the synthesized peptide is noncytotoxic. The hydrogel showed an antibacterial efficacy against Gram-positive and Gram-negative bacteria. In vivo anti-inflammatory activity of the hydrogel was investigated using the rat air pouch model of acute inflammation. The major parameters considered for the anti-inflammatory study were exudate volume, total and differential white blood cell count, tissue histology, and lipid peroxidation assay. These experimental data suggest biocompatibility and potential therapeutic applications of peptide hydrogel in inflammation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
August 1993, Pediatric research,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
February 2012, Inflammation,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
December 2017, Advanced pharmaceutical bulletin,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
January 2015, Inflammation & allergy drug targets,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
January 2014, International journal of nanomedicine,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
February 2020, Research in pharmaceutical sciences,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
June 1995, The Journal of pharmacy and pharmacology,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
June 2000, Journal of biomedical materials research,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
January 2017, PloS one,
Pramod K Gavel, and Hamendra S Parmar, and Versha Tripathi, and Narendra Kumar, and Ankan Biswas, and Apurba K Das
January 2017, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!